Source:http://linkedlifedata.com/resource/pubmed/id/18497550
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
2008-5-23
|
| pubmed:abstractText |
Cytokeratin 8 (CK8) is a type II intermediate filament protein that is persistently expressed in most epithelial malignancies. Circulating CK-related polypeptides have commonly been used as tumor markers. While apoptosis is a mechanism of CK release, the molecular nature of circulating CKs is poorly understood. The aim is to clarify the dynamics of CK8 during apoptosis in vitro and the nature of circulating CK8 in patients with lung cancer.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
1423-0380
|
| pubmed:author | |
| pubmed:copyrightInfo |
(c) 2008 S. Karger AG, Basel
|
| pubmed:issnType |
Electronic
|
| pubmed:volume |
29
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
57-62
|
| pubmed:meshHeading |
pubmed-meshheading:18497550-Apoptosis,
pubmed-meshheading:18497550-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:18497550-Cell Line, Tumor,
pubmed-meshheading:18497550-Etoposide,
pubmed-meshheading:18497550-Humans,
pubmed-meshheading:18497550-Keratin-8,
pubmed-meshheading:18497550-Lung Neoplasms,
pubmed-meshheading:18497550-Tumor Markers, Biological
|
| pubmed:year |
2008
|
| pubmed:articleTitle |
Full-length cytokeratin 8 is released and circulates in patients with non-small cell lung cancer.
|
| pubmed:affiliation |
First Department of Internal Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan.
|
| pubmed:publicationType |
Journal Article
|